• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VISIONIST X4 CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VISIONIST X4 CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P) Back to Search Results
Model Number U228
Device Problems Pacing Problem (1439); Use of Device Problem (1670)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/15/2020
Event Type  malfunction  
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) patient was experiencing inappropriate pacing percentages and therapy loss, despite the device programmed to left ventricular-only mode.Boston scientific technical services was contacted and it was discussed that a right ventricular (rv) lead was not implanted in the system, which is off-label usage.Because the crt-p operation is based on right ventricular (rv) based timing, it was strongly recommended to implant a rv lead to resolve the event.It is unknown if the therapy loss resulted in asystole or a health impact.Additional information has been requested regarding the event resolution and physician name, but has not yet been received.At this time, the device remains implanted and no additional adverse patient consequences were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) patient was experiencing inappropriate pacing percentages and therapy loss, despite the device programmed to left ventricular-only mode.Boston scientific technical services was contacted and it was discussed that a right ventricular (rv) lead was not implanted in the system, which is off-label usage.Because the crt-p operation is based on right ventricular (rv) based timing, it was strongly recommended to implant a rv lead to resolve the event.However, despite multiple attempts, no further information was able to be provided for this event.At this time, the device remains implanted and no additional adverse patient consequences were reported.
 
Manufacturer Narrative
With all the available information, bsc is unable to conclude the root cause of the incident.This device has not been returned; therefore, a technical analysis cannot be conducted.Without a returned device it is not possible to definitively confirm how the device may have contributed to the complaint incident.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIONIST X4 CRT-P
Type of Device
PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11228012
MDR Text Key228620443
Report Number2124215-2021-01902
Device Sequence Number1
Product Code NKE
Combination Product (y/n)N
PMA/PMN Number
P030005/S138
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/19/2021
Device Model NumberU228
Device Catalogue NumberU228
Device Lot Number744118
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/22/2020
Initial Date FDA Received01/25/2021
Supplement Dates Manufacturer Received03/03/2021
Supplement Dates FDA Received04/07/2021
Patient Sequence Number1
-
-